ARCHIVES

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 30 | July 30, 1999

Download PDF Visit The Full Archive

Related Articles

ONS Accredited As Approver, Provider Of Continuing Education

April 22, 1988

ASCO Honors Eight With Special Awards

May 24, 2002

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

June 30, 2006

NCI Committee Attempts To Redesign Cooperative Groups Without Doing Harm

June 12, 1998

Cervical Screening Should Emphasize Older Women, ASP Members Told

March 14, 1986

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002